Moffitt’s Updated Visitor Policy
Taking Care of Your Health
Taking Care of Your Health features cancer-related information, health tips, patient stories and more.
Research Education and Training
We are interested in recruiting scholars who have a profound interest in preventing, treating and curing cancer.
Ways to Give
Cancer touches all of us. Our mission - to contribute to the prevention and cure of cancer - depends on your support.
Moffitt’s research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances.
Centers and Institutes
Moffitt’s Centers and Institutes promote translation across research and the clinic to address the needs of the catchment area.
Divisions and Departments
Moffitt’s research departments are typically discipline-based and focus on the career development of our faculty from appointment to tenure.
Moffitt's five research programs, supported in part by the Cancer Center Support Grant (CCSG), consist of integrative teams working together to tackle cancer.
Moffitt directly employs over 150 faculty representing a diverse group of scientists and physicians, all dedicated to cancer research.
Faculty members are encouraged to form teams around specific topics, no matter how informal, to take research in new directions.
Community Outreach, Engagement, and Equity
The COEE works to uphold Moffitt's commitment to maximize the impact of its research in the community.
Shared Resources provide Moffitt investigators access to the latest technologies and highly skilled services to foster productivity.
Academic and Industry Partnerships
Moffitt’s extensive research partnerships reflect a longstanding commitment to working with others in the fight against cancer.
Latest Research News
Moffitt’s W. Gregory Sawyer, Ph.D., Awarded BioFlorida’s Entrepreneur of the Year
The award honors those who have made extraordinary contributions to the growth of the state’s life sciences industry
Moffitt Research Finds Non-Small Cell Lung Cancer Drug Lorlatinib Targets Additional Protein
Lorlatinib co-targets PYK2 and forms a multiprotein complex with SRC suggesting combo therapy could be more beneficial for patients
Moffitt Receives $10.4 Million to Develop Treatment Strategies to Overcome Drug Resistance in Lung Cancer
The five-year grant will utilize ecological and evolutionary principles to study non-small cell lung cancer
Si no encuentra la información que busca o si desea programar una cita, llámenos gratis al 1-888-663-3488.